Natural Product: NPC475614
Natural Product ID:   | NPC475614 |
Common Name:   | Mimosamycin |
IUPAC Name:   | 7-methoxy-1,2,6-trimethylisoquinoline-3,5,8-trione |
Synonyms:   | Mimosamycin |
Molecular Formula:   | C13H13NO4 |
Standard InCHIKey:   | ZYWCMKYDEGVQCK-UHFFFAOYSA-N |
Standard InCHI:   | InChI=1S/C13H13NO4/c1-6-11(16)8-5-9(15)14(3)7(2)10(8)12(17)13(6)18-4/h5H,1-4H3 |
Canonical SMILES:   | COC1=C(C)C(=O)c2c(C1=O)c(C)n(c(=O)c2)C |
First Find Year:   | |
Max Developmental Stage:   | |
Synthetic Gene Cluster:   |
; |
  Species Source
Organism ID |
Organism Name |
Taxonomy Level |
Family |
SuperKingdom |
Isolation Part |
Collection Location |
Collection Time |
Reference |
NPO33502 |
Haliclona sp. |
Species |
Chalinidae |
Eukaryota |
|
|
|
PMID[11575970] |
  Biological Activity
Activity Type |
# Activity |
EC50 |
1 |
IC50 |
2 |
Others |
7 |
Activity Type |
# Activity |
Cell Line |
1 |
Individual Protein |
1 |
Organism |
7 |
Others |
1 |
Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT2709 |
Organism |
Bacillus subtilis subsp. subtilis str. 168 |
Bacillus subtilis subsp. subtilis str. 168 |
IZ |
= |
22 |
mm |
11473426 |
NPT776 |
Organism |
Spodoptera littoralis |
Spodoptera littoralis |
Activity |
= |
15 |
% |
11473426 |
NPT3973 |
Individual Protein |
Endothelial PAS domain-containing protein 1 |
Homo sapiens |
EC50 |
> |
100000 |
nM |
17452481 |
NPT16 |
Organism |
Staphylococcus aureus |
Staphylococcus aureus |
IZ |
= |
17 |
mm |
PubChem BioAssay data set |
NPT985 |
Organism |
Cladosporium cucumerinum |
Cladosporium cucumerinum |
IZ |
= |
15 |
mm |
24144848 |
NPT985 |
Organism |
Cladosporium cucumerinum |
Cladosporium cucumerinum |
IZ |
= |
18 |
mm |
24144848 |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
10 |
ug/ml |
8864236 |
NPT985 |
Organism |
Cladosporium cucumerinum |
Cladosporium cucumerinum |
IZ |
= |
15 |
mm |
26034885 |
NPT985 |
Organism |
Cladosporium cucumerinum |
Cladosporium cucumerinum |
IZ |
= |
18 |
mm |
22439674 |
NPT377 |
Cell Line |
OVCAR-3 |
Homo sapiens |
IC50 |
= |
10 |
ug/ml |
17850214 |
  Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC475614 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 50 |
0.1-0.2 | 547 |
0.2-0.3 | 8680 |
0.3-0.4 | 17377 |
0.4-0.5 | 3946 |
0.5-0.6 | 258 |
0.6-0.7 | 30 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 1 |
0.95-1 | 0 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC475614 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 70 |
0.1-0.2 | 477 |
0.2-0.3 | 4060 |
0.3-0.4 | 3950 |
0.4-0.5 | 581 |
0.5-0.6 | 21 |
0.6-0.7 | 2 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6279 |
Remote Similarity |
NPD6108 |
Clinical (unspecified phase) |
0.6129 |
Remote Similarity |
NPD4756 |
Discovery |
0.593 |
Remote Similarity |
NPD2664 |
Clinical (unspecified phase) |
0.5909 |
Remote Similarity |
NPD3704 |
Approved |
0.5882 |
Remote Similarity |
NPD7299 |
Clinical (unspecified phase) |
0.575 |
Remote Similarity |
NPD7196 |
Clinical (unspecified phase) |
0.5745 |
Remote Similarity |
NPD1452 |
Discontinued |
0.5714 |
Remote Similarity |
NPD5115 |
Clinical (unspecified phase) |
0.5714
|
Remote Similarity |
NPD8779 |
Phase 3 |